BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors in 2003 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
131
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. BioArctic AB - Ordinary Shares Class B market cap is $2.67B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioArctic AB - Ordinary Shares Class B 52 week high is $40.00 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioArctic AB - Ordinary Shares Class B 52 week low is $29.26 as of November 21, 2026.
BioArctic AB - Ordinary Shares Class B stock price today is $30.10.
BioArctic AB - Ordinary Shares Class B stock price yesterday was $30.00.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. BioArctic AB - Ordinary Shares Class B's P/E ratio is 222.8.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. BioArctic AB - Ordinary Shares Class B P/B ratio is 12.819.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. BioArctic AB - Ordinary Shares Class B 50-day moving average is $32.37.
BioArctic AB - Ordinary Shares Class B has 131 employees.